Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Canadian, Non-interventional, Cohort Study of the Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adult Patients Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)

NCT03580668 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT03580668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03580668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Canadian, Non-interventional, Cohort Study of the Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adult Patients Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
November 13, 2018
Completion date
June 3, 2024
Enrollment
201 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection